ABBOTT LABORATORIES Financing Cash Flow
ABBOTT LABORATORIES (ABT) reported Financing Cash Flow of $17.31 billion for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-04-29
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $17.31B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$1.40B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$1.76B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for the quarter ending 2025-06-30 was -$1.10B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for fiscal 2025 was -$6.31B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for fiscal 2024 was -$5.40B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for fiscal 2023 was -$7.09B.
- ABBOTT LABORATORIES net cash provided by (used in) financing activities for fiscal 2022 was -$7.64B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $17.31B 10-Q · filed 2026-04-29 | $15.92B derived: sum of 2 quarters · filed 2026-04-29 | $14.16B derived: sum of 3 quarters · filed 2026-04-29 | $13.06B derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-12-31 | -$1.40B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$3.16B derived: sum of 2 quarters · filed 2026-02-20 | -$4.25B derived: sum of 3 quarters · filed 2026-02-20 | -$6.31B 10-K · filed 2026-02-20 | |||
| 2025-09-30 | -$1.76B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$2.86B derived: sum of 2 quarters · filed 2025-10-29 | -$4.91B 10-Q · filed 2025-10-29 | -$6.77B derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-06-30 | -$1.10B derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$3.15B 10-Q · filed 2025-07-30 | -$5.01B derived: sum of 3 quarters · filed 2026-04-29 | -$6.59B derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2025-03-31 | -$2.06B 10-Q · filed 2026-04-29 | -$3.92B derived: sum of 2 quarters · filed 2026-04-29 | -$5.49B derived: sum of 3 quarters · filed 2026-04-29 | -$6.28B derived: sum of 4 quarters · filed 2026-04-29 | |||
| 2024-12-31 | -$1.86B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$3.44B derived: sum of 2 quarters · filed 2026-02-20 | -$4.23B derived: sum of 3 quarters · filed 2026-02-20 | -$5.40B 10-K · filed 2026-02-20 | |||
| 2024-09-30 | -$1.58B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$2.37B derived: sum of 2 quarters · filed 2025-10-29 | -$3.54B 10-Q · filed 2025-10-29 | -$5.59B derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2024-06-30 | -$791.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | -$1.97B 10-Q · filed 2025-07-30 | -$4.02B derived: sum of 3 quarters · filed 2026-02-20 | -$6.36B derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2024-03-31 | -$1.18B 10-Q · filed 2025-04-30 | -$3.23B derived: sum of 2 quarters · filed 2026-02-20 | -$5.57B derived: sum of 3 quarters · filed 2026-02-20 | -$6.86B derived: sum of 4 quarters · filed 2026-02-20 | |||
| 2023-12-31 | -$2.05B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$4.39B derived: sum of 2 quarters · filed 2026-02-20 | -$5.68B derived: sum of 3 quarters · filed 2026-02-20 | -$7.09B 10-K · filed 2026-02-20 | |||
| 2023-09-30 | -$2.34B derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$3.63B derived: sum of 2 quarters · filed 2024-10-31 | -$5.04B 10-Q · filed 2024-10-31 | -$6.50B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-06-30 | -$1.29B derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | -$2.70B 10-Q · filed 2024-07-31 | -$4.16B derived: sum of 3 quarters · filed 2025-02-21 | -$5.70B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2023-03-31 | -$1.41B 10-Q · filed 2024-05-02 | -$2.87B derived: sum of 2 quarters · filed 2025-02-21 | -$4.41B derived: sum of 3 quarters · filed 2025-02-21 | -$5.22B derived: sum of 4 quarters · filed 2025-02-21 | |||
| 2022-12-31 | -$1.46B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$3.00B derived: sum of 2 quarters · filed 2025-02-21 | -$3.81B derived: sum of 3 quarters · filed 2025-02-21 | -$7.64B 10-K · filed 2025-02-21 | |||
| 2022-09-30 | -$1.54B derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$2.36B derived: sum of 2 quarters · filed 2023-11-01 | -$6.18B 10-Q · filed 2023-11-01 | -$8.06B derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-06-30 | -$813.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.64B 10-Q · filed 2023-08-03 | -$6.52B derived: sum of 3 quarters · filed 2024-02-16 | -$7.90B derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2022-03-31 | -$3.82B 10-Q · filed 2023-05-04 | -$5.71B derived: sum of 2 quarters · filed 2024-02-16 | -$7.09B derived: sum of 3 quarters · filed 2024-02-16 | -$8.35B derived: sum of 4 quarters · filed 2024-02-16 | |||
| 2021-12-31 | -$1.89B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$3.26B derived: sum of 2 quarters · filed 2024-02-16 | -$4.53B derived: sum of 3 quarters · filed 2024-02-16 | -$5.49B 10-K · filed 2024-02-16 | |||
| 2021-09-30 | -$1.38B derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$2.64B derived: sum of 2 quarters · filed 2022-11-01 | -$3.61B 10-Q · filed 2022-11-01 | -$4.39B derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-06-30 | -$1.26B derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$2.23B 10-Q · filed 2022-08-02 | -$3.02B derived: sum of 3 quarters · filed 2023-02-17 | -$4.93B derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2021-03-31 | -$967.00M 10-Q · filed 2022-05-03 | -$1.75B derived: sum of 2 quarters · filed 2023-02-17 | -$3.67B derived: sum of 3 quarters · filed 2023-02-17 | -$3.01B derived: sum of 4 quarters · filed 2023-02-17 | |||
| 2020-12-31 | -$787.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$2.70B derived: sum of 2 quarters · filed 2023-02-17 | -$2.04B derived: sum of 3 quarters · filed 2023-02-17 | -$2.78B 10-K · filed 2023-02-17 | |||
| 2020-09-30 | -$1.92B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$1.26B derived: sum of 2 quarters · filed 2021-11-03 | -$1.99B 10-Q · filed 2021-11-03 | -$4.18B derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-06-30 | $658.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | -$77.00M 10-Q · filed 2021-08-04 | -$2.26B derived: sum of 3 quarters · filed 2022-02-18 | -$2.77B derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-03-31 | -$735.00M 10-Q · filed 2021-05-05 | -$2.92B derived: sum of 2 quarters · filed 2022-02-18 | -$3.43B derived: sum of 3 quarters · filed 2022-02-18 | -$3.88B derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2019-12-31 | -$2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$2.70B derived: sum of 2 quarters · filed 2022-02-18 | -$3.15B derived: sum of 3 quarters · filed 2022-02-18 | -$4.29B 10-K · filed 2022-02-18 | |||
| 2019-09-30 | -$513.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | -$962.00M derived: sum of 2 quarters · filed 2020-11-04 | -$2.10B 10-Q · filed 2020-11-04 | -$6.88B derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2019-06-30 | -$449.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$1.59B 10-Q · filed 2020-07-29 | -$6.37B derived: sum of 3 quarters · filed 2021-02-19 | -$3.90B derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2019-03-31 | -$1.14B 10-Q · filed 2020-04-29 | -$5.92B derived: sum of 2 quarters · filed 2021-02-19 | -$3.45B derived: sum of 3 quarters · filed 2021-02-19 | -$5.08B derived: sum of 4 quarters · filed 2021-02-19 | |||
| 2018-12-31 | -$4.78B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$2.31B derived: sum of 2 quarters · filed 2021-02-19 | -$3.94B derived: sum of 3 quarters · filed 2021-02-19 | -$10.39B 10-K · filed 2021-02-19 | |||
| 2018-09-30 | $2.47B derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $840.00M derived: sum of 2 quarters · filed 2019-10-31 | -$5.62B 10-Q · filed 2019-10-31 | -$5.73B derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-06-30 | -$1.63B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$8.09B 10-Q · filed 2019-07-31 | -$8.20B derived: sum of 3 quarters · filed 2020-02-21 | -$8.58B derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2018-03-31 | -$6.46B 10-Q · filed 2019-05-01 | -$6.57B derived: sum of 2 quarters · filed 2020-02-21 | -$6.95B derived: sum of 3 quarters · filed 2020-02-21 | -$7.34B derived: sum of 4 quarters · filed 2020-02-21 | |||
| 2017-12-31 | -$112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$498.00M derived: sum of 2 quarters · filed 2020-02-21 | -$882.00M derived: sum of 3 quarters · filed 2020-02-21 | -$5.28B 10-K · filed 2020-02-21 | |||
| 2017-09-30 | -$386.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$770.00M derived: sum of 2 quarters · filed 2018-10-31 | -$5.17B 10-Q · filed 2018-10-31 | $8.34B derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-06-30 | -$384.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$4.78B 10-Q · filed 2018-08-01 | $8.72B derived: sum of 3 quarters · filed 2019-02-22 | $7.97B derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2017-03-31 | -$4.40B 10-Q · filed 2018-05-02 | $9.11B derived: sum of 2 quarters · filed 2019-02-22 | $8.36B derived: sum of 3 quarters · filed 2019-02-22 | $8.18B derived: sum of 4 quarters · filed 2019-02-22 | |||
| 2016-12-31 | $13.50B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | $12.76B derived: sum of 2 quarters · filed 2019-02-22 | $12.58B derived: sum of 3 quarters · filed 2019-02-22 | $11.15B 10-K · filed 2019-02-22 | |||
| 2016-09-30 | -$746.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$925.00M derived: sum of 2 quarters · filed 2017-11-02 | -$2.36B 10-Q · filed 2017-11-02 | -$2.85B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | -$179.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$1.61B 10-Q · filed 2017-08-02 | -$2.11B derived: sum of 3 quarters · filed 2018-02-16 | -$2.92B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | -$1.43B 10-Q · filed 2017-05-03 | -$1.93B derived: sum of 2 quarters · filed 2018-02-16 | -$2.74B derived: sum of 3 quarters · filed 2018-02-16 | -$3.12B derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | -$497.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$1.31B derived: sum of 2 quarters · filed 2018-02-16 | -$1.69B derived: sum of 3 quarters · filed 2018-02-16 | -$2.24B 10-K · filed 2018-02-16 | |||
| 2015-09-30 | -$815.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.19B derived: sum of 2 quarters · filed 2016-11-03 | -$1.74B 10-Q · filed 2016-11-03 | -$2.44B derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-06-30 | -$374.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$924.00M 10-Q · filed 2016-08-03 | -$1.62B derived: sum of 3 quarters · filed 2017-02-17 | -$1.90B derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-03-31 | -$550.00M 10-Q · filed 2016-05-04 | -$1.25B derived: sum of 2 quarters · filed 2017-02-17 | -$1.52B derived: sum of 3 quarters · filed 2017-02-17 | -$2.14B derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2014-12-31 | -$700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$971.00M derived: sum of 2 quarters · filed 2017-02-17 | -$1.59B derived: sum of 3 quarters · filed 2017-02-17 | -$2.74B 10-K · filed 2017-02-17 | |||
| 2014-09-30 | -$271.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$890.00M derived: sum of 2 quarters · filed 2015-11-05 | -$2.04B 10-Q · filed 2015-11-05 | -$3.91B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-06-30 | -$619.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | -$1.77B 10-Q · filed 2015-08-04 | -$3.64B derived: sum of 3 quarters · filed 2016-02-19 | -$4.20B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2014-03-31 | -$1.15B 10-Q · filed 2015-05-06 | -$3.02B derived: sum of 2 quarters · filed 2016-02-19 | -$3.58B derived: sum of 3 quarters · filed 2016-02-19 | -$3.12B derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | -$1.87B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$2.43B derived: sum of 2 quarters · filed 2016-02-19 | -$1.96B derived: sum of 3 quarters · filed 2016-02-19 | -$6.70B 10-K · filed 2016-02-19 | |||
| 2013-09-30 | -$559.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$94.00M derived: sum of 2 quarters · filed 2014-11-06 | -$4.83B 10-Q · filed 2014-11-06 | -$4.83B 10-Q · filed 2013-11-07 | -$2.32B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $465.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$4.27B 10-Q · filed 2014-08-05 | -$4.27B 10-Q · filed 2013-08-06 | -$1.76B derived: sum of 3 quarters · filed 2015-02-27 | -$4.35B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | -$4.73B 10-Q · filed 2014-05-07 | -$4.73B 10-Q · filed 2013-05-08 | -$2.23B derived: sum of 2 quarters · filed 2015-02-27 | -$4.82B derived: sum of 3 quarters · filed 2015-02-27 | -$4.70B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $2.51B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | -$85.59M derived: sum of 2 quarters · filed 2015-02-27 | $29.77M derived: sum of 3 quarters · filed 2015-02-27 | $195.00M 10-K · filed 2015-02-27 | |||
| 2012-09-30 | -$2.59B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$2.48B derived: sum of 2 quarters · filed 2013-11-07 | -$2.31B 10-Q · filed 2013-11-07 | ||||
| 2012-06-30 | $115.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $280.59M 10-Q · filed 2013-08-06 | |||||
| 2012-03-31 | $165.22M 10-Q · filed 2013-05-08 | ||||||
| 2011-12-31 | -$6.42B 10-K · filed 2014-02-21 | ||||||
| 2011-06-30 | -$1.39B derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$2.07B 10-Q · filed 2011-08-04 | -$2.16B derived: sum of 3 quarters · filed 2011-08-04 | -$2.85B derived: sum of 4 quarters · filed 2011-08-04 | |||
| 2011-03-31 | -$684.33M 10-Q · filed 2011-05-06 | -$777.65M derived: sum of 2 quarters · filed 2011-05-06 | -$1.46B derived: sum of 3 quarters · filed 2011-05-06 | -$1.25B derived: sum of 4 quarters · filed 2011-08-04 | |||
| 2010-12-31 | -$93.31M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$780.42M derived: sum of 2 quarters · filed 2011-02-18 | -$567.54M derived: sum of 3 quarters · filed 2011-08-04 | -$1.09B 10-K · filed 2011-02-18 | |||
| 2010-09-30 | -$687.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | -$474.23M derived: sum of 2 quarters · filed 2011-08-04 | -$994.43M 10-Q · filed 2010-11-05 | -$491.05M derived: sum of 4 quarters · filed 2011-08-04 | |||
| 2010-06-30 | $212.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-04 | -$307.32M 10-Q · filed 2011-08-04 | $196.05M derived: sum of 3 quarters · filed 2011-08-04 | -$660.28M derived: sum of 4 quarters · filed 2011-08-04 | |||
| 2010-03-31 | -$520.20M 10-Q · filed 2011-05-06 | -$16.83M derived: sum of 2 quarters · filed 2011-05-06 | -$873.16M derived: sum of 3 quarters · filed 2011-05-06 | -$1.20B derived: sum of 4 quarters · filed 2011-05-06 | |||
| 2009-12-31 | $503.37M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$352.96M derived: sum of 2 quarters · filed 2011-02-18 | -$682.58M derived: sum of 3 quarters · filed 2011-02-18 | $1.00B 10-K · filed 2011-02-18 | |||
| 2009-09-30 | -$856.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | -$1.19B derived: sum of 2 quarters · filed 2010-11-05 | $498.65M 10-Q · filed 2010-11-05 | $546.52M derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2009-06-30 | -$329.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-05 | $1.35B 10-Q · filed 2010-08-05 | $1.40B derived: sum of 3 quarters · filed 2011-02-18 | -$1.96B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2009-03-31 | $1.68B 10-Q · filed 2010-05-04 | $1.73B derived: sum of 2 quarters · filed 2011-02-18 | -$1.63B derived: sum of 3 quarters · filed 2011-02-18 | ||||
| 2008-12-31 | $47.88M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | -$3.32B derived: sum of 2 quarters · filed 2011-02-18 | -$3.49B 10-K · filed 2011-02-18 | ||||
| 2008-09-30 | -$3.37B derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-06 | -$3.53B 10-Q · filed 2009-11-06 | |||||
| 2008-06-30 | -$168.58M 10-Q · filed 2009-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |